HO-1 Upregulation Attenuates Adipocyte Dysfunction, Obesity, and Isoprostane Levels in Mice Fed High Fructose Diets

Journal of Nutrition and Metabolism

Volumn 2014, Issue , 2014, Pages

  Khitan, Zeid ^a   Harsh, Mohit ^a   Sodhi, Komal ^a   Shapiro, Joseph I ^a   Abraham, Nader G ^a,b  

^a MARSHALL UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MUS;

EID: 84935917310     PISSN: 20900724     EISSN: 20900732     Source Type: Journal    
DOI: 10.1155/2014/980547     Document Type: Article

References (61)

1. J. J. Rumessen and E. Gudmand-Hoyer, "Absorption capacity of fructose in healthy adults. Comparison with sucrose and its constituentmonosaccharides," Gut, vol. 27, no. 10, pp. 1161-1168, 1986.
2. R. J. Johnson, S. E. Perez-Pozo, Y. Y. Sautin et al., "Hypothesis: could excessive fructose intake and uric acid cause type 2 diabetes?" Endocrine Reviews, vol. 30, no. 1, pp. 96-116, 2009.
3. R. J. Johnson, M. S. Segal, Y. Sautin et al., "Potential role of sugar (fructose) in the epidemic of hypertension, obesity and the metabolic syndrome, diabetes, kidney disease, and cardiovascular disease," The American Journal of Clinical Nutrition, vol. 86, no. 4, pp. 899-906, 2007.
4. T. Ishimoto, M. A. Lanaspa, M. T. Le et al., "Opposing effects of fructokinase C and A isoforms on fructose-induced metabolic syndrome in mice," Proceedings of the National Academy of Sciences of theUnited States of America, vol. 109, no. 11, pp. 4320-4325, 2012.
5. F.Q. Zhao and A. F. Keating, "Functional properties and genomics of glucose transporters," Current Genomics, vol. 8, no. 2, pp. 113-128, 2007.
6. K. L. Stanhope, J. M. Schwarz, N. L. Keim et al., "Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans," The Journal of Clinical Investigation, vol. 119, no. 5, pp. 1322-1334, 2009.
7. N. G. Abraham and A. Kappas, "Pharmacological and clinical aspects of heme oxygenase," Pharmacological Reviews, vol. 60, no. 1, pp. 79-127, 2008.
8. D. Sacerdoti, R. Olszanecki, G. Li Volti, C. Colombrita, G. Scapagnini, and N. G. Abraham, "Heme oxygenase overexpression attenuates glucose-mediated oxidative stress in quiescent cell phase: linking heme to hyperglycemia complications," Current Neurovascular Research, vol. 2, no. 2, pp. 103-111, 2005.
9. J. Balla, H. S. Jacob, G. Balla, K. Nath, J. W. Eaton, and G. M. Vercellotti, "Endothelial-cell heme uptake from heme proteins: Induction of sensitization and desensitization to oxidant damage," Proceedings of the National Academy of Sciences of the United States of America, vol. 90, no. 20, pp. 9285-9289, 1993.
10. D. Sacerdoti, C. Colombrita, M. H. Ghattas et al., "Heme oxygenase-1 transduction in endothelial cells causes downregulation of monocyte chemoattractant protein-1 and of genes involved in inflammation and growth," Cellular and Molecular Biology, vol. 51, no. 4, pp. 363-370, 2005.
11. N. G. Abraham, T. Kushida, J. McClung et al., "Heme oxygenase- 1 attenuates glucose-mediated cell growth arrest and apoptosis in human microvessel endothelial cells," Circulation Research, vol. 93, pp. 504-514, 2003.
12. T. Yura, M. Fukunaga, R. Khan, G. N. Nassar, K. F. Badr, and A. Montero, "Free-radical-generated F2-isoprostane stimulates cell proliferation and endothelin-1 expression on endothelial cells," Kidney International, vol. 56, no. 2, pp. 471-478, 1999.
13. J. D. Morrow and L. J. Roberts, "The isoprostanes: unique bioactive products of lipid peroxidation," Progress in Lipid Research, vol. 36, no. 1, pp. 1-21, 1997.
14. J. A. Awad, J.-L. Horn, L. J. Roberts II, and J. J. Franks, "Demonstration of halothane-induced hepatic lipid peroxidation in rats by quantification of F 2-isoprostanes," Anesthesiology, vol. 84, no. 4, pp. 910-916, 1996.
15. I. J. Tsai, K. D. Croft, T. A. Mori et al., "20-HETE and F2- isoprostanes in the metabolic syndrome: the effect of weight reduction," Free Radical Biology andMedicine, vol. 46, no. 2, pp. 263-270, 2009.
16. J. F. Keaney Jr., M. G. Larson, R. S. Vasan et al., "Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham study," Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 23, no. 3, pp. 434-439, 2003.
17. P. Faure, C. Polge, D. Monneret, A. Favier, and S. Halimi, "Plasma 15-F2t isoprostane concentrations are increased during acute fructose loading in type 2 diabetes," Diabetes & Metabolism, vol. 34, no. 2, pp. 148-154, 2008.
18. M. Hokayem, E. Blond, H. Vidal et al., "Grape polyphenols prevent fructose-induced oxidative stress and insulin resistance in first-degree relatives of type 2 diabetic patients," Diabetes Care, vol. 36, no. 6, pp. 1454-1461, 2013.
19. Z. Khitan and D. H. Kim, "Fructose: a key factor in the development ofmetabolic syndrome and hypertension," Journal of Nutrition and Metabolism, vol. 2013, Article ID 682673, 12 pages, 2013.
20. P. Vestergaard, "Bone metabolism in type 2 diabetes and role of thiazolidinediones," CurrentOpinion in Endocrinology, Diabetes and Obesity, vol. 16, no. 2, pp. 125-131, 2009.
21. S. Gesta, Y.-H. Tseng, and C. R. Kahn, "Developmental origin of fat: tracking obesity to its source," Cell, vol. 131, no. 2, pp. 242-256, 2007.
22. H. Clevers, "Wnt/β-catenin signaling in development and disease," Cell, vol. 127, no. 3, pp. 469-480, 2006.
23. K. M. Cadigan and Y. I. Liu, "Wnt signaling: complexity at the surface," Journal of Cell Science, vol. 119, no. 3, pp. 395-402, 2006.
24. J. Cao, S. J. Peterson, K. Sodhi et al., "Heme oxygenase gene targeting to adipocytes attenuates adiposity and vascular dysfunction in mice fed a high-fat diet," Hypertension, vol. 60, no. 2, pp. 467-475, 2012.
25. L. Vanella, D. H. Kim, K. Sodhi et al., "Crosstalk between EET and HO-1 downregulates Bach1 and adipogenic marker expression in mesenchymal stem cell derived adipocytes," Prostaglandins and Other Lipid Mediators, vol. 96, no. 1-4, pp. 54-62, 2011.
26. N. Puri, K. Sodhi, M. Haarstad et al., "Heme induced oxidative stress attenuates sirtuin1 and enhances adipogenesis in mesenchymal stem cells and mouse pre-adipocytes," Journal of Cellular Biochemistry, vol. 113, no. 6, pp. 1926-1935, 2012.
27. M. Li, D. H. Kim, P. L. Tsenovoy et al., "Treatment of obese diabetic mice with a heme oxygenase inducer reduces visceral and subcutaneous adiposity, increases adiponectin levels, and improves insulin sensitivity and glucose tolerance," Diabetes, vol. 57, no. 6, pp. 1526-1535, 2008.
28. S. J. Peterson, D. H. K. Kim, M. Li et al., "The L-4F mimetic peptide prevents insulin resistance through increased levels of HO-1, pAMPK, and pAKT in obese mice," Journal of Lipid Research, vol. 50, no. 7, pp. 1293-1304, 2009.
29. A. Nicolai, M. Li, D.H. Kim et al., "Heme oxygenase-1 induction remodels adipose tissue and improves insulin sensitivity in obesity-induced diabetic rats," Hypertension, vol. 53, no. 3, pp. 508-515, 2009.
30. S. J. Peterson, G. Drummond, D. H. Kim et al., "L-4F treatment reduces adiposity, increases adiponectin levels, and improves insulin sensitivity in obese mice," Journal of Lipid Research, vol. 49, no. 8, pp. 1658-1669, 2008.
31. A. L. Kruger, S. J. Peterson, M. L. Schwartzman et al., "Upregulation of heme oxygenase provides vascular protection in an animal model of diabetes through its antioxidant and antiapoptotic effects," Journal of Pharmacology and Experimental Therapeutics, vol. 319, no. 3, pp. 1144-1152, 2006.
32. Y. Shen, N. C. Ward, J. M. Hodgson et al., "Dietary quercetin attenuates oxidant-induced endothelial dysfunction and atherosclerosis in apolipoprotein E knockout mice fed a high-fat diet: a critical role for heme oxygenase-1," Free Radical Biology & Medicine, vol. 65, pp. 908-915, 2013.
33. J.-L. da Silva, M. Tiefenthaler, E. Park et al., "Tin-mediated heme oxygenase gene activation and cytochrome P450 arachidonate hydroxylase inhibition in spontaneously hypertensive rats," American Journal of the Medical Sciences, vol. 307, no. 3, pp. 173-181, 1994.
34. N. G. Abraham, J.-M. Camadro, S. T. Hoffstein, and R. D. Levere, "Effects of iron deficiency and chronic iron overloading on mitochondrial heme biosynthetic enzymes in rat liver," Biochimica et Biophysica Acta-Protein Structure andMolecular Enzymology, vol. 870, no. 2, pp. 339-349, 1986.
35. B. M. Grossman, M. L. Devore, E.W. Kelso, and R. J. Martin, "Effect of glucose and 2-deoxyglucose on hypothalamic GABA release in lactating rats," Physiology & Behavior, vol. 61, no. 2, pp. 169-173, 1997.
36. E. Scharrer, "Control of food intake by fatty acid oxidation and ketogenesis," Nutrition, vol. 15, no. 9, pp. 704-714, 1999.
37. M. A. Rupnick, D. Panigrahy, C.-Y. Zhang et al., "Adipose tissue mass can be regulated through the vasculature," Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 16, pp. 10730-10735, 2002.
38. M. Morimura, O. Ishiko, T. Sumi, H. Yoshida, and S. Ogita, "Angiogenesis in adipose tissues and skeletal muscles with rebound weight-gain after diet-restriction in rabbits," International Journal of Molecular Medicine, vol. 8, no. 5, pp. 499-503, 2001.
39. S. R. Datla, G. J. Dusting, T. A. Mori, C. J. Taylor, K. D. Croft, and F. Jiang, "Induction of heme oxygenase-1 in vivo suppresses NADPH oxidase-derived oxidative stress," Hypertension, vol. 50, no. 4, pp. 636-642, 2007.
40. T. Chabrashvili, C. Kitiyakara, J. Blau et al., "Effects of ANG II type 1 and 2 receptors on oxidative stress, renal NADPHoxidase, and SODexpression,"TheAmerican Journal of Physiology-Regulatory Integrative and Comparative Physiology, vol. 285, no. 1, pp. R117-R124, 2003.
41. K. Sodhi, N. Puri, D. H. Kim et al., "PPARδ binding to heme oxygenase 1 promoter prevents angiotensin II-induced adipocyte dysfunction in Goldblatt hypertensive rats," International Journal of Obesity, vol. 38, no. 3, pp. 456-465, 2014.
42. A. Burgess, M. Li, L. Vanella et al., "Adipocyte heme oxygenase- 1 induction attenuates metabolic syndrome in both male and female obese mice," Hypertension, vol. 56, no. 6, pp. 1124-1130, 2010.
43. K. L. Stanhope and P. J. Havel, "Fructose consumption: potential mechanisms for its effects to increase visceral adiposity and induce dyslipidemia and insulin resistance," Current Opinion in Lipidology, vol. 19, no. 1, pp. 16-24, 2008.
44. N. G. Abraham, T. Kushida, J. McClung et al., "Heme oxygenase-1 attenuates glucose-mediated cell growth arrest and apoptosis in human microvessel endothelial cells," Circulation Research, vol. 93, no. 6, pp. 507-514, 2003.
45. A. L. Kruger, S. Peterson, S. Turkseven et al., "D-4F induces heme oxygenase-1 and extracellular superoxide dismutase, decreases endothelial cell sloughing, and improves vascular reactivity in rat model of diabetes," Circulation, vol. 111, no. 23, pp. 3126-3134, 2005.
46. N. G. Abraham, "Heme oxygenase attenuated angiotensin IImediated increase in cyclooxygenase activity and decreased isoprostane F2α in endothelial cells," Thrombosis Research, vol. 110, no. 5-6, pp. 305-309, 2003.
47. C. Colombrita, G. Lombardo, G. Scapagnini, and N. G. Abraham, "Heme oxygenase-1 expression levels are cell cycle dependent," Biochemical and Biophysical Research Communications, vol. 308, no. 4, pp. 1001-1008, 2003.
48. N. G. Abraham, R. Rezzani, L. Rodella et al., "Overexpression of human heme oxygenase-1 attenuates endothelial cell sloughing in experimental diabetes,"TheAmerican Journal of Physiology- Heart and Circulatory Physiology, vol. 287, no. 6, pp. H2468- H2477, 2004.
49. N. Kumar, L. A. Solt, Y. Wang et al., "Regulation of adipogenesis by natural and synthetic REV-ERB ligands," Endocrinology, vol. 151, no. 7, pp. 3015-3025, 2010.
50. J. E. Clark, R. Foresti, C. J. Green, and R. Motterlini, "Dynamics of haem oxygenase-1 expression and bilirubin production in cellular protection against oxidative stress," Biochemical Journal, vol. 348, no. 3, pp. 615-619, 2000.
51. J. Neuzil and R. Stocker, "Free and albumin-bound bilirubin are efficient co-antioxidants for α-tocopherol, inhibiting plasma and low density lipoprotein lipid peroxidation," The Journal of Biological Chemistry, vol. 269, no. 24, pp. 16712-16719, 1994.
52. J.Y. Kwak, K. Takeshige, B.S. Cheung, and S. Minakami, "Bilirubin inhibits the activation of superoxide-producing NADPH oxidase in a neutrophil cell-free system," Biochimica et Biophysica Acta-Protein Structure andMolecular Enzymology, vol. 1076, no. 3, pp. 369-373, 1991.
53. K. Sano, H. Nakamura, and T. Matsuo, "Mode of inhibitory action of bilirubin on protein kinase C," Pediatric Research, vol. 19, no. 6, pp. 587-590, 1985.
54. D. E. Barañano, M. Rao, C. D. Ferris, and S. H. Snyder, "Biliverdin reductase: a major physiologic cytoprotectant," Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 25, pp. 16093-16098, 2002.
55. L. Vanella, K. Sodhi, D. H. Kim et al., "Increased hemeoxygenase 1 expression in mesenchymal stem cell-derived adipocytes decreases differentiation and lipid accumulation via upregulation of the canonicalWnt signaling cascade," Stem Cell Research andTherapy, vol. 4, no. 2, article 28, 2013.
56. M. Kawai, S. Mushiake, K. Bessho et al., "Wnt/Lrp/β-catenin signaling suppresses adipogenesis by inhibiting mutual activation of PPARγ and C/EBPα," Biochemical and Biophysical Research Communications, vol. 363, no. 2, pp. 276-282, 2007.
57. M. Okamura, H. Kudo, K.-I. Wakabayashi et al., "COUP-TFII acts downstream of Wnt/β-catenin signal to silence PPARγ gene expression and repress adipogenesis," Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 14, pp. 5819-5824, 2009.
58. M. Takahashi, Y. Kamei, and O. Ezaki, "Mest/Peg1 imprinted gene enlarges adipocytes and is a marker of adipocyte size," The American Journal of Physiology-Endocrinology and Metabolism, vol. 288, no. 1, pp. E117-E124, 2005.
59. L. Vanella, D. H. Kim, D. Asprinio et al., "HO-1 expression increases mesenchymal stem cell-derived osteoblasts but decreases adipocyte lineage," Bone, vol. 46, no. 1, pp. 236-243, 2010.
60. Y. Kamei, T. Suganami, T. Kohda et al., "Peg1/Mest in obese adipose tissue is expressed from the paternal allele in an isoform-specific manner," FEBS Letters, vol. 581, no. 1, pp. 91-96, 2007.
61. R. A. Koza, L. Nikonova, J. Hogan et al., "Changes in gene expression foreshadowdiet-induced obesity in genetically identical mice," PLoS Genetics, vol. 2, no. 5, article e81, 2006.